28
Episodes
5
Ratings
Monthly
Cadence
2021
First episode

About A Chat with Anat

"A Chat with Anat" is a series for ophthalmologists who are interested in improving delivery of care for patients living with retinal disease, and for those interested in clinically-challenging situations or controversies in care. I’m Professor Anat Loewenstein, Chair of the Department of Ophthalmology at Tel Aviv Sourasky Medical Centre in Israel, and Professor of Ophthalmology and Vice Dean at Tel Aviv University. For each episode, I will be joined by internationally renowned colleagues to discuss these important topics. This podcast series is sponsored and organized by Bayer Consumer Care AG and produced by ApotheCom. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise. This is not intended for UK audiences.

Publisher
ApotheCom
Category
science
Language
en
Explicit
No
First episode
1 Oct 2021
Latest episode
31 Aug 2026

Latest episodes

28 episodes in the feed.

  1. 31 Aug 2026

    GLP-1 receptor agonists and vision health: What ophthalmologists should know

  2. 6 Jul 2026

    Oculomics: From insight to practice

  3. 12 Jun 2026

    Early Signals and Global Stories from the HCP Barometer Survey

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Spotify
5.0 / 5
5 ratings

Podcast Authority Score: 16 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality
9
Social presence
0
YouTube
0
Engagement
60

Contact A Chat with Anat

Guest appearances
Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Host of A Chat with Anat?

Claim your podcast to manage its listing and keep your show details accurate.

Claim this podcast

Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.

Explore this show
Podcast research with Pod Engine

See plans